Aegerion Pharmaceuticals, Inc listed on Nasdaq in 2010. (Nasdaq:AEGR)
Website www.aegerion.com
FDA Advisory Committee Recommends Approval of Lomitapide for Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), announces the pricing of its initial public offering of 5,000,000 shares of its common stock at $9.50 per share